The value added of chemical and pharmaceutical products in Denmark has shown a generally positive trajectory from 2013 to 2023. The market stood at 110.84 billion Danish Krones in 2023, reflecting consistent growth. However, the rate of growth has decelerated over time. From 2013 to 2015, growth rates were in double digits, but from 2020 onwards, year-on-year growth slowed to less than 4%. The CAGR also decreased, showcasing a significant slowing in growth rate from 13.55% in 2013 to 3.63% in 2023.

Future forecasts predict a continuation of this trend, with an expected CAGR of 2.23% from 2024 to 2028, and an overall 11.66% growth rate over the next five years.

Future trends to watch for include:

Potential impacts of global economic conditions on the Danish pharmaceutical and chemical sectors.
Technological advancements and innovations driving efficiency and value addition.
Regulatory changes within the European Union affecting production and value chain.
Shifts in consumer demand, particularly towards sustainable and eco-friendly products.